Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,688 | 426 | 99.6% |
| Education | $23.59 | 3 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,518 | 88 | $0 (2024) |
| PFIZER INC. | $967.48 | 55 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $595.45 | 45 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $383.55 | 22 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $355.19 | 37 | $0 (2023) |
| ABBVIE INC. | $352.45 | 11 | $0 (2024) |
| Lilly USA, LLC | $340.00 | 25 | $0 (2023) |
| Amgen Inc. | $273.38 | 14 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $247.15 | 16 | $0 (2022) |
| Novo Nordisk Inc | $230.05 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $480.02 | 26 | Amgen Inc. ($107.05) |
| 2023 | $1,189 | 62 | AbbVie Inc. ($290.21) |
| 2022 | $916.08 | 64 | AstraZeneca Pharmaceuticals LP ($260.36) |
| 2021 | $908.38 | 52 | AstraZeneca Pharmaceuticals LP ($240.16) |
| 2020 | $657.72 | 40 | AstraZeneca Pharmaceuticals LP ($187.35) |
| 2019 | $753.98 | 50 | AstraZeneca Pharmaceuticals LP ($289.61) |
| 2018 | $662.51 | 46 | AstraZeneca Pharmaceuticals LP ($228.63) |
| 2017 | $1,144 | 89 | AstraZeneca Pharmaceuticals LP ($201.57) |
All Payment Transactions
429 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Inflammation | ||||||
| 09/25/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/05/2024 | Organogenesis Inc. | — | Food and Beverage | In-kind items and services | $20.69 | General |
| 09/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 08/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: IMMUNOLOGY | ||||||
| 07/30/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: Inflammation | ||||||
| 07/29/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/25/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: Diabetes Care | ||||||
| 06/18/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Psychology/Psychiatric | ||||||
| 05/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/22/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $25.04 | General |
| Category: Inflammation | ||||||
| 05/21/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 05/07/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Diabetes | ||||||
| 04/29/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/03/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: Psychology/Psychiatric | ||||||
| 04/02/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Oncology | ||||||
| 03/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $27.61 | General |
| Category: Inflammation | ||||||
| 02/19/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/15/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: Psychology/Psychiatric | ||||||
| 01/24/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 749 | 2,278 | $381,944 | $206,081 |
| 2022 | 8 | 661 | 1,891 | $293,793 | $145,759 |
| 2021 | 8 | 752 | 1,990 | $289,751 | $152,423 |
| 2020 | 8 | 838 | 2,253 | $326,622 | $144,814 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 181 | 1,181 | $224,390 | $127,981 | 57.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 180 | 533 | $116,804 | $57,465 | 49.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 56 | 80 | $13,440 | $6,758 | 50.3% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 63 | 75 | $11,625 | $5,660 | 48.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 56 | 56 | $4,760 | $4,245 | 89.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 139 | 263 | $8,679 | $2,209 | 25.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 56 | 56 | $1,960 | $1,646 | 84.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 18 | 34 | $286.00 | $115.94 | 40.5% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Facility | 2022 | 100 | 786 | $149,340 | $72,153 | 48.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 196 | 553 | $117,236 | $59,349 | 50.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 52 | 74 | $11,848 | $6,000 | 50.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 54 | 54 | $4,320 | $3,794 | 87.8% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 23 | 31 | $4,805 | $1,822 | 37.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 59 | 59 | $2,056 | $1,640 | 79.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 159 | 305 | $3,985 | $903.57 | 22.7% |
| 81002 | Urinalysis, manual test | Office | 2022 | 18 | 29 | $203.00 | $99.45 | 49.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 201 | 613 | $129,956 | $69,234 | 53.3% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Facility | 2021 | 99 | 662 | $125,780 | $66,421 | 52.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 66 | 87 | $13,920 | $7,441 | 53.5% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 40 | 69 | $10,695 | $4,515 | 42.2% |
| 90756 | Vaccine for influenza derived from cell cultures for injection into muscle, quadrivalent, antibiotic free, 0.5ml dosage | Office | 2021 | 81 | 81 | $2,349 | $2,298 | 97.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 81 | 81 | $2,106 | $1,307 | 62.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 162 | 361 | $4,693 | $1,083 | 23.1% |
| 81002 | Urinalysis, manual test | Office | 2021 | 22 | 36 | $252.00 | $125.28 | 49.7% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Facility | 2020 | 142 | 885 | $168,150 | $81,619 | 48.5% |
About Dr. James Rocco, M.D
Dr. James Rocco, M.D is a Internal Medicine healthcare provider based in Wakefield, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1710075346.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Rocco, M.D has received a total of $6,711 in payments from pharmaceutical and medical device companies, with $480.02 received in 2024. These payments were reported across 429 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($6,688).
As a Medicare-enrolled provider, Rocco has provided services to 3,000 Medicare beneficiaries, totaling 8,412 services with total Medicare billing of $649,077. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Wakefield, MI
- Active Since 10/10/2006
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1710075346
Products in Payments
- ELIQUIS (Drug) $878.13
- FARXIGA (Drug) $872.80
- ENTRESTO (Drug) $546.89
- JARDIANCE (Drug) $484.99
- Kerendia (Drug) $355.19
- VRAYLAR (Drug) $352.45
- CHANTIX (Drug) $273.54
- BREZTRI (Drug) $231.23
- Otezla (Drug) $217.68
- SYMBICORT (Drug) $210.87
- REXULTI (Drug) $183.08
- BEVESPI AEROSPHERE (Drug) $149.63
- Victoza (Drug) $137.04
- Vascepa (Drug) $131.61
- FreeStyle Libre (Device) $100.67
- TOUJEO (Drug) $92.07
- LONHALA MAGNAIR (Drug) $91.22
- Auvelity (Drug) $73.93
- FREESTYLE LIBRE 2 (Device) $73.86
- NUPLAZID (Drug) $72.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Wakefield
Dr. Bruce Watrous, M.d, M.D
Internal Medicine — Payments: $9,530
Monique Pouliot, D.o, D.O
Internal Medicine — Payments: $3,120
Dr. Nitin Damle, Md, MD
Internal Medicine — Payments: $3,102
Heidi Dorris, M.d, M.D
Internal Medicine — Payments: $3,009
Paul Barratt, M.d, M.D
Internal Medicine — Payments: $2,857
Dr. Griffin Reynolds, Md, MD
Internal Medicine — Payments: $2,808